Historical context and limitations of the group
These medicinal products entered clinical practice in the 1980s with the ambitious goal of replacing traditional cardiac glycosides. Initially, pharmaceutical companies developed convenient oral formulations, including compounds such as ibopamine or milrinone.
However, clinical use revealed a serious problem: at therapeutic dosages, toxic manifestations occur significantly more frequently and are more severe than with glycoside treatment. The main consequence of the long-term use of such medications was an increase in overall patient mortality. For this reason, today they are used briefly, exclusively in emergency care settings.
Classification of non-glycoside cardiotonics
Modern pharmacology divides all drugs in this group into three major categories based on their primary molecular action:
- Beta1-adrenoreceptor agonists — these include classic beta1-adrenomimetics (Dobutamine) and dopaminomimetics (Dopamine).
- Phosphodiesterase type III inhibitors — a prominent representative is Milrinone.
- Calcium sensitizers — a unique group that includes Levosimendan.
Characteristics of catecholamines and PDE inhibitors
Dobutamine stimulates myocardial beta1-receptors via Gs proteins and the activation of adenylate cyclase, leading to cAMP accumulation, opening of calcium channels, and a potent positive inotropic effect. The drug is administered exclusively via intravenous drip, acts rapidly (peak at 10 minutes), and has a half-life of only 2 minutes. Similarly, Dopamine is a precursor of norepinephrine and exhibits pronounced dose-dependency: low doses dilate renal blood vessels, while high doses produce a pressor effect due to the stimulation of alpha-adrenoreceptors.
Milrinone inhibits the phosphodiesterase-III enzyme in cardiomyocytes and the vascular wall. This leads to intracellular cAMP accumulation, increased myocardial contractility, and simultaneous direct vasodilation, which reduces total peripheral vascular resistance.
Features of calcium sensitizers
The drug Levosimendan differs fundamentally from classical inotropes. Its molecular target is the N-terminal region of troponin C. The drug increases the sensitivity of contractile proteins to calcium ions, but does not increase their intracellular concentration.
Binding to troponin occurs selectively during systole, so diastolic ventricular relaxation is not impaired. Additionally, the drug activates ATP-sensitive potassium channels in vascular smooth muscle, causing pronounced vasodilation. Due to the absence of cellular calcium overload, levosimendan has a much lower arrhythmogenic potential compared to catecholamines.
Briefly: answers to topical questions
What is the dose-dependent effect of dopamine?
The dose-dependent effect of dopamine lies in its varying impact on blood vessel tone.
- Low doses — stimulate dopamine receptors, causing dilation of renal and mesenteric vessels. This leads to increased renal blood flow, glomerular filtration rate, and elevated diuresis and sodium excretion.
- High doses — stimulate $\alpha_1$-adrenoreceptors, which causes increased peripheral vascular tone, systemic vasoconstriction, and a pronounced pressor effect.
What specific side effects are caused by non-glycoside cardiotonics?
Non-glycoside cardiotonics cause various side effects depending on the specific drug.
- Dobutamine — provokes tachycardia, ventricular and supraventricular arrhythmias.
- Dopamine — causes peripheral vasoconstriction, elevated blood pressure, tachycardia, arrhythmias, anginal pain (angina pectoris), as well as dyspeptic disorders (nausea, vomiting).
- Milrinone — has an arrhythmogenic effect, causes anginal pain and thrombocytopenia.
- Levosimendan — is characterized by a low arrhythmogenic potential; its side effects are limited to hypotension and headache.
Which drugs belong to the group of phosphodiesterase type III inhibitors?
Milrinone belongs to the group of phosphodiesterase type III inhibitors. The drug selectively inhibits the phosphodiesterase-III isoenzyme in cardiomyocytes, preventing the degradation of secondary messengers. This leads to the accumulation of intracellular cAMP, prolonged activation of calcium channels, increased influx of calcium ions into the cell, and enhanced myocardial contraction. In blood vessels, non-selective enzyme inhibition causes direct vasodilation.
D-M-L: Dobutamine contracts (beta), Milrinone relaxes vessels (PDE), Levosimendan senses calcium without overload (troponin).
Class and exam questions
Why are non-glycoside cardiotonics not used for the long-term treatment of chronic heart failure?
In therapeutic doses, these drugs cause more frequent and severe toxic effects than cardiac glycosides. Their long-term use reliably increases patient mortality rates.
What is the main pharmacological difference between levosimendan and dobutamine?
Dobutamine increases intracellular calcium concentration via the cAMP system, which creates a risk of arrhythmias. Levosimendan increases the sensitivity of troponin C to calcium without increasing its intracellular level, reducing the risk of arrhythmogenic action.
What are the features of the dose-dependent action of dopamine?
At low doses, dopamine selectively stimulates dopamine receptors and dilates renal and mesenteric vessels. At high doses, it activates alpha-adrenoreceptors, increasing peripheral vascular tone and exerting a pressor effect.
What else to study on this topic
- Time parameters and pharmacokinetics of dobutamine
- Metabolism and renal excretion of dobutamine
- Dose-dependent vascular effects of dopamine
- Pharmacokinetic profile and plasma protein binding of levosimendan
- The role of active metabolites of levosimendan in prolonging its effect
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Non-glycoside cardiotonics" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.